# Clinical Intervention Strategy for High-risk Group of Hepatitis B Related Hepatocellular Carcinoma

> **NCT05256459** · — · UNKNOWN · sponsor: **Zhang Dazhi,MD** · enrollment: 1000 (estimated)

## Conditions studied

- Time

## Interventions

- **OTHER:** Long term follow-up

## Key facts

- **NCT ID:** NCT05256459
- **Lead sponsor:** Zhang Dazhi,MD
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-05-10
- **Primary completion:** 2024-12-15
- **Final completion:** 2024-12-15
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2022-05-09

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05256459

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05256459, "Clinical Intervention Strategy for High-risk Group of Hepatitis B Related Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05256459. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*